Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded Vitamin Shoppe

from Overweight to Neutral. The target price for Vitamin Shoppe has been lowered from $45 to $44. Vitamin Shoppe's shares closed at $45.40 yesterday. Analysts at RBC Capital downgraded Athlon Energy

from Outperform to Sector Perform. The target price for Athlon Energy has been raised from $55 to $59. Athlon Energy's shares closed at $58.32 yesterday. Analysts at Bank of America downgraded Seattle Genetics

from Neutral to Underperform. The target price for Seattle Genetics has been lowered from $ $40 to $34. Seattle Genetics' shares closed at $38.39 yesterday. Analysts at Brean Capital downgraded Endocyte

from Buy to Hold. Endocyte's shares closed at $6.99 yesterday.